Summary:
A Multicenter, Randomized, Double-blind Trial of Brexpiprazole versus Placebo for the
Acute Treatment of Manic Episodes, With or Without Mixed Features, Associated With
Bipolar I Disorder
Qualified Participants Must:
Men and women 18 to 65 years of age
Qualified Participants May Receive:
Compensation for time and travel